Clarity Wealth Advisors LLC Cuts Position in iShares Biotechnology ETF (NASDAQ:IBB)

Clarity Wealth Advisors LLC cut its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 9.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 12,520 shares of the financial services provider’s stock after selling 1,309 shares during the quarter. Clarity Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,655,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Park Avenue Securities LLC acquired a new stake in shares of iShares Biotechnology ETF in the third quarter valued at approximately $218,000. Albion Financial Group UT grew its holdings in iShares Biotechnology ETF by 0.3% during the 3rd quarter. Albion Financial Group UT now owns 129,980 shares of the financial services provider’s stock valued at $18,925,000 after buying an additional 356 shares during the last quarter. Valeo Financial Advisors LLC purchased a new position in iShares Biotechnology ETF during the third quarter worth $206,000. CenterStar Asset Management LLC purchased a new stake in shares of iShares Biotechnology ETF in the third quarter valued at $386,000. Finally, Martin Capital Advisors LLP boosted its stake in shares of iShares Biotechnology ETF by 1.0% during the third quarter. Martin Capital Advisors LLP now owns 13,169 shares of the financial services provider’s stock valued at $1,918,000 after acquiring an additional 133 shares during the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB stock opened at $137.67 on Friday. The firm has a 50-day moving average price of $136.22 and a 200 day moving average price of $141.41. iShares Biotechnology ETF has a twelve month low of $123.60 and a twelve month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.